Entering text into the input field will update the search result below

Akers Biosciences reports FY results

Apr. 11, 2017 7:05 AM ETMyMD Pharmaceuticals, Inc. (MYMD) StockBy: Niloofer Shaikh, SA News Editor
  • Akers Biosciences (AKER): FY Net loss of $3.3M
  • Revenue of $2.96M (+39.6% Y/Y)
  • Press Release

Recommended For You

More Trending News

About MYMD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MYMD--
MyMD Pharmaceuticals, Inc.